SphygmoCor®-teknologi: er Cardiex' banebrydende teknologi, som har sat standarden for ikke-invasiv måling af centrale aortatryk og relaterede arterielle sundhedskarakteristika, samlet kendt som vaskulære biomarkører. Denne teknologi er blevet grundigt undersøgt og beskrevet i adskillige fagfællebedømte tidsskrifter, og den bruges til at vurdere hjerte-kar-risiko, forudsige organskade og vejlede sygdomsbehandling.
Omfattende indsigt i hjerte-kar-sundhed
SphygmoCor XCEL er en avanceret vaskulær biometrisk monitor, designet til at give omfattende indsigt i centrale hæmodynamik og arteriel stivhed, hvilket muliggør fuld indsigt i hjerte-kar-sundhed. Ved at måle både centrale og brachiale blodtryk giver den vigtige oplysninger om hjerte-kar-funktionen.
Key Features
Noninvasive Measurement: The SphygmoCor XCEL enables the noninvasive assessment of central aortic pressure waveforms and vascular biomarkers that are crucial for understanding cardiovascular health.
Advanced Physiological Measurements: It assesses vascular biomarkers for a thorough understanding of arterial stiffness and overall arterial health. This allows for early detection of potential cardiovascular issues, guiding targeted interventions for improving cardiovascular health.
Importance of Arterial Health
The need for new methods to assess arterial pressure and flow dynamics is highlighted by the Lancet Commission on Hypertension. Traditional methods often focus solely on upper-arm blood pressure, overlooking vital insights offered by advanced measurements.
Pulse Wave Analysis (PWA)
What It Does: PWA analyzes the characteristics of the arterial pulse wave, providing valuable insights into the elasticity and compliance of arterial walls.
Benefits: This analysis goes beyond conventional blood pressure measurements, offering a comprehensive understanding of vascular health and aiding in early detection of cardiovascular risk.
Pulse Wave Velocity (PWV)
Definition: PWV measures the speed at which the arterial pulse travels through the circulatory system. Elevated PWV is a key indicator of arterial stiffness.
Significance: Monitoring PWV is crucial for assessing vascular aging and guiding interventions to maintain or enhance cardiovascular health.
Comprehensive Parameter Overview
The SphygmoCor XCEL provides a wide range of measurements that are essential for evaluating cardiovascular health:
Parameter Description Heart Rate (HR) Beat-to-beat measurement aligned with standard ECG methods. Brachial Blood Pressure Pressure at the brachial artery; high levels are a major risk factor for heart disease. Central Blood Pressure More accurate predictor of subclinical cardiovascular disease than traditional brachial blood pressure. Central Pulse Pressure Indicates the pressure experienced by major organs, essential for assessing end organ damage risk. Augmentation Pressure (AP) Marker indicating arterial stiffness; elevated levels reflect increased cardiovascular risk. Augmentation Index (AIx) Another indicator of arterial stiffness, reflecting the burden on the heart. Subendocardial Viability Ratio (SEVR) Insight into how well the heart copes with exercise stress. Pulse Pressure Amplification (PPA) Provides insights into arterial stiffness and efficiency of blood flow distribution. Pulse Wave Velocity (PWV) Key indicator of arterial stiffness and cardiovascular risk. SphygmoCor Reference Age Estimated arterial age based on central pressure and stiffness parameters.
Trusted Technology
Founded on over 40 years of hemodynamic studies and validated by more than 20 years of research, SphygmoCor technology is trusted by researchers worldwide. It has supported clinical trials across various therapeutic areas, including hypertension, heart failure, chronic kidney disease, COPD, and diabetes.
For clinical research or practice, the SphygmoCor XCEL stands as a pivotal tool for understanding cardiovascular health and guiding patient management strategies effectively.
For more information on the SphygmoCor XCEL and its applications, please contact us.